An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma
暂无分享,去创建一个
Ahmet Dogan | Rafael Fonseca | Ming-Qing Du | Peter G. Isaacson | Rifat A. Hamoudi | R. Fonseca | L. de Leval | P. Isaacson | O. el-Maarri | R. Hamoudi | M. Du | E. Braggio | A. Dogan | Laurence de Leval | Hongxiang Liu | A. J. Watkins | Yuanxue Huang | Hongxiang Liu | E. McPhail | Naiyan Zeng | A. Wotherspoon | Andrew Wotherspoon | Q. Yan | Naiyan Zeng | Yuanxue Huang | Esteban Braggio | A. James Watkins | Qingguo Yan | Jianzhong Zhang | Ellen D. McPhail | Jianzhong Zhang
[1] Guidel Ines,et al. Expression profiling — best practices for data generation and interpretation in clinical trials , 2004, Nature Reviews Genetics.
[2] Fei Li,et al. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. , 2010, Biochemical and biophysical research communications.
[3] N. Varol,et al. The realm of microRNAs in cancers , 2011, Molecular Biology Reports.
[4] J. Cheville,et al. Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate Cancer , 2009, Cancer investigation.
[5] J. Delabie,et al. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. , 2004, The Journal of molecular diagnostics : JMD.
[6] M. Mateo,et al. MicroRNA losses in the frequently deleted region of 7q in SMZL , 2007, Leukemia.
[7] P. Isaacson,et al. Clonality analysis of defined B‐cell populations in archival tissue sections using microdissection and the polymerase chain reaction , 1994, Histopathology.
[8] Geoffrey Hom,et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus , 2007, Proceedings of the National Academy of Sciences.
[9] D. Catovsky,et al. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes , 2003, Genes, chromosomes & cancer.
[10] L. de Leval,et al. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis , 2010, The Journal of pathology.
[11] Crispin J. Miller,et al. Cell Culture , 2010, Cell.
[12] E. Campo,et al. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. , 2005, Blood.
[13] M. Gratacós,et al. Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia. , 2010, Human molecular genetics.
[14] J. Herman,et al. Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer , 2011, Clinical Cancer Research.
[15] J. Epplen,et al. A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener’s granulomatosis , 2010, Journal of Molecular Medicine.
[16] M. Piris,et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. , 1999, The American journal of pathology.
[17] M Paulli,et al. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection , 2012, Leukemia.
[18] Claudio G. Rolli,et al. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma , 2012, Acta Neuropathologica.
[19] André Kajdacsy-Balla,et al. miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate Cells* , 2011, The Journal of Biological Chemistry.
[20] K. Honda,et al. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression , 2007, Proceedings of the National Academy of Sciences.
[21] Jun Liu,et al. microRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-associated protein. , 2011, International journal of molecular medicine.
[22] G. Salles,et al. MicroRNA expression profile in splenic marginal zone lymphoma , 2012, British journal of haematology.
[23] K. Basso,et al. Identification of the human mature B cell miRNome. , 2009, Immunity.
[24] Philippe Hupé,et al. SMETHILLIUM: spatial normalization METHod for ILLumina InfinIUM HumanMethylation BeadChip , 2011, Bioinform..
[25] K. Maclennan,et al. Differential expression of NF-κB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism , 2010, Leukemia.
[26] Robert Tibshirani,et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.
[27] I. Lossos,et al. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities , 2012, Modern Pathology.
[28] M. Gorospe,et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. , 2011, Molecular cell.
[29] T. Ushijima,et al. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines. , 2006, Cancer letters.
[30] R. Warnke,et al. Splenic B‐Cell Marginal Zone Lymphoma , 2011 .
[31] P. Gaulard,et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. , 2004, Blood.
[32] H. Lee,et al. Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma. , 2009, Oncology reports.
[33] R. Gregory,et al. Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.